Opportunities and challenges for the adoption of novel platform technologies to develop veterinary bacterial vaccines.

Saved in:
Bibliographic Details
Title: Opportunities and challenges for the adoption of novel platform technologies to develop veterinary bacterial vaccines.
Authors: Entrican G; The Roslin Institute at University of Edinburgh, Easter Bush Campus, Midlothian EH25 9RG, UK. Electronic address: gary.entrican@roslin.ed.ac.uk., Bredell H; Afrigen Biologics and Vaccines, 5 Kestrel Park, Longclaw Drive, Montague Gardens, Cape Town, South Africa., Charlier J; Kreavet, Hendrik Mertensstraat 17, 9150 Kruibeke, Belgium., Cunningham AF; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK., Jarvis MA; The Vaccine Group Limited, 14 Research Way, Derriford Research Facility, Plymouth Science Park, Plymouth PL6 8BU, UK; School of Biomedical Sciences, University of Plymouth, Drake Circus, Plymouth PL4 8AA, UK., Wood PR; Department of Microbiology, Monash University, Clayton, VIC 3800, Australia., Wren BW; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Hope JC; The Roslin Institute at University of Edinburgh, Easter Bush Campus, Midlothian EH25 9RG, UK.
Source: Vaccine [Vaccine] 2025 Apr 30; Vol. 54, pp. 127117. Date of Electronic Publication: 2025 Apr 14.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2025.127117